Carvedilol Tablet, Film Coated
Product Images NDC 68071-4956

6 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 68071-4956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4956 6)

Pdp (68071 4956 6)
Label for Carvedilol 25 mg film-coated tablets, oral use, manufactured by Cadila Healthcare Ltd. India and packaged by NuCare Pharmaceuticals, Inc., Orange, CA. The package contains 60 tablets. Label includes NDC 68071-4956-6, product number P1856060, and tablet description as round white/off-white with 'ZC42' debossed on one side. Directions and warnings are present, along with lot, serial, and expiration date placeholders.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)
Chemical structure diagram of carvedilol showing its molecular arrangement including aromatic rings and functional groups as depicted in the image.*
FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)
A line graph comparing percent mortality over 22 months between Carvedilol and placebo groups. The x-axis shows time in months, and the y-axis shows percent mortality, with Carvedilol consistently below placebo, indicating lower mortality. A p-value of 0.0014 is noted on the graph.*
FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)
A forest plot showing hazard ratios with confidence intervals for different patient subgroups including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use, as well as overall results for all patients. The horizontal axis represents the hazard ratio scale from 0.0 to 2.0.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)
A line graph depicting percent mortality over a 24-month period, comparing Carvedilol to placebo. The x-axis represents months, while the y-axis shows percentage mortality. The graph indicates a lower mortality curve for Carvedilol compared to placebo, with a noted P value of 0.03.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)
A hazard ratio plot presenting comparative data on various patient groups and conditions, including age, gender, prior MI timing, prior use of IV oral beta-blockers, Killip classification, thrombolytic use, PTCA for MI, CHF status, diuretic use during MI, angina presence, hypertension, diabetes, heart rate, and systolic blood pressure. The plot displays hazard ratios with confidence intervals for these categories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.